United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Technology Industry News Bumble Inc. reports staggering $892.2m impairment charge in Q3 2024 In a dramatic financial downturn, Bumble Inc. has reported a colossal net loss of $922.6 million for the… byPallavi MadhirajuNovember 7, 2024